[Trends in oral cancer mortality in China from 2004 to 2021].

Trends and future burden of major digestive system cancers in Jiangsu Province, China, 2010–2030

Jiangsu Province is experiencing a transition in digestive system cancer burden, with continued declines in esophageal, gastric, and liver cancers but an emerging and growing burden of colorectal cancer, especially colon cancer.

Trends in cervical cancer incidence and mortality in Mongolia, 2014–2024: a population-based analysis of pandemic-related disruptions

Divergent trends between incidence and mortality likely reflect reduced detection during the pandemic rather than true changes in disease burden, and highlight the importance of maintaining continuity of cancer screening and diagnostic services during health-system disruptions.

Gastric Cancer Mortality in Mexico: Past Trends, Current Burden, and Future Perspectives.

BACKGROUND Gastric cancer remains a significant cause of mortality worldwide. This study analyzed gastric cancer mortality trends over 24 years, projections for 2030, and their relationship with indigenous populations and gastroenterology services in Mexico. METHODS The study was based on mortality data from the Mini...

Trends and Projections of Esophageal Cancer Incidence and Mortality in China, 1990 to 2050: An Analysis of the Global Burden of Disease Study 2023.

GOALS The study aims to analyze and project esophageal cancer trends in China from 1990 to 2023 using GBD 2023 data. BACKGROUND Esophageal cancer (EC) remains a major public health challenge in China. Updated evidence on long-term trends and future burden is needed to inform prevention and control strategies. METHO...

The thirty years trends of gastric cancer attributable to smoking in China and Japan: Demographic decomposition and age-period-cohort analysis.

Temporal Trends in Lung Cancer and Histological Subtype Incidence and Bayesian Projections to 2030 in China: Population-Based Quantitative Study.

BACKGROUND Lung cancer is the leading cause of cancer-related death globally, with a significant burden in China, which accounts for more than one-third of the world's new cases and 40% of related mortalities. Despite evidence that low-dose computed tomography screening can reduce mortality, its limited uptake in China...